Obesity drug brings heart health benefit alongside weight loss – study
DUBLIN — Taking Novo Nordisk’s new obesity drug may help reduce the risk of heart disease as well as boost weight loss, according to new research from the United States. After a year of taking semaglutide, marketed as Wegovy, patients’ risk of suffering from conditions like a heart attack or a stroke over the next […]
The post Obesity drug brings heart health benefit alongside weight loss – study appeared first on Inquirer Technology.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.